Escalon Medical Corp.
ESMC
$0.208
$0.000.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -1.74% | -5.61% | -1.63% | -2.60% | 13.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.74% | -5.61% | -1.63% | -2.60% | 13.23% |
| Cost of Revenue | 2.08% | -0.66% | 2.04% | 1.18% | 7.45% |
| Gross Profit | -6.17% | -11.50% | -6.11% | -7.00% | 20.76% |
| SG&A Expenses | 5.61% | 9.23% | 9.04% | 3.20% | -2.35% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.42% | 1.64% | 3.28% | 0.49% | 1.62% |
| Operating Income | -70.27% | -114.87% | -121.81% | -111.49% | 228.24% |
| Income Before Tax | -72.88% | -118.01% | -127.40% | -119.84% | 219.80% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -72.88% | -118.01% | -127.40% | -119.84% | 219.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -72.88% | -118.01% | -127.40% | -119.84% | 219.80% |
| EBIT | -70.27% | -114.87% | -121.81% | -111.49% | 228.24% |
| EBITDA | -66.29% | -108.51% | -111.15% | -100.08% | 248.83% |
| EPS Basic | -94.57% | -136.04% | -179.87% | -215.27% | 172.21% |
| Normalized Basic EPS | -73.01% | -118.05% | -127.53% | -120.00% | 219.92% |
| EPS Diluted | -102.30% | -182.25% | -140.40% | -700.00% | 129.26% |
| Normalized Diluted EPS | -79.21% | -134.02% | -223.26% | -439.47% | 157.88% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | -13.77% | -29.60% | -29.60% | 0.95% | 42.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
